References
- PURNOMO HD, PERMATADEWI CO, PRASETYO A, INDIARSO D, HUTAMI HT, PUSPASARI D, et al. Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study. PLoS One. 2023;18(1):e0279570.
- ANGULO-AGUADO M, ORJUELA-AMARILLO S, MORA-JÁCOME JF, CÓRDOBA LP, GALLEGO-ORTIZ A, GAVIRIA-SABOGAL CC, et al. Functional analysis of CTLA4 promoter variant and its possible implication in colorectal cancer immunotherapy. Front Med (Lausanne). 2023;10:1160368.
- ZOU C, QIU H, TANG W, WANG Y, LAN B, CHEN Y. CTLA4 tagging polymorphisms and risk of colorectal cancer: A case-control study involving 2,306 subjects. Onco Targets Ther. 2018;11:4609–19.
- BRAY F, LAVERSANNE M, SUNG H, FERLAY J, SIEGEL RL, SOERJOMATARAM I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
- PURNOMO HD, PERMATADEWI CO, PRASETYO A, INDIARSO D, HUTAMI HT, PUSPASARI D, et al. Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study. PLoS One. 2023;18(1):e0279570.
- HAN SW, KIM HP, SHIN JY, JEONG EG, LEE WC, LEE KH, et al. Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS One. 2013;8(5):e64271.
- NARAYANAN V, PAVITHRA V, DHANAPAL D, SUNDARAM S, NARAYANAN CD. Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers. Indian J Pathol Microbiol. 2022;65(4):791–5.
- AKHTAR MS. The variant allele frequency of CTLA-4 rs11571317 (−658 C/T) polymorphism with colorectal cancer susceptibility in the Saudi population and other ethnic groups. Cureus. 2023;15(12):e50091.
- LI J, WANG W, SUN Y, ZHU Y. CTLA-4 polymorphisms and predisposition to digestive system malignancies: A meta-analysis of 31 published studies. World J Surg Oncol. 2020;18:55.
- WAN H, ZHOU H, FENG Y, CHEN Y, ZHU L, MI Y. Comprehensive analysis of 29,464 cancer cases and 35,858 controls to investigate the effect of the cytotoxic T-lymphocyte antigen 4 gene rs231775 A/G polymorphism on cancer risk. Front Oncol. 2022;12:878507.
- WANG L, JING F, SU D, ZHANG T, YANG B, JIAO S, et al. Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: A meta-analysis. Int J Clin Exp Med. 2015;8(1):650–7.
- NGUYEN SV, SHAMOUN L, LANDERHOLM K, ANDERSSON RE, WAGSATER D, DIMBERG J. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism (rs3087243) is related to risk and survival in patients with colorectal cancer. In Vivo. 2021;35(2):969–75.
- AL-HARBI N, ABDULLA MH, VAALI-MOHAMMED MA, BIN TRAIKI T, ALSWAYYED M, AL-OBEED O, et al. Evidence of association between CTLA-4 gene polymorphisms and colorectal cancers in Saudi patients. Genes (Basel). 2023;14(4):874.
- LIN TC, CHIEN WC, HU JM, TZENG NS, CHUNG CH, PU TW, et al. Risk of colorectal cancer in patients with alcoholism: A nationwide, population-based nested case-control study. PLoS One. 2020;15(5):e0232740.
- PARK SY, WILKENS LR, SETIAWAN VW, MONROE KR, HAIMAN CA, LE MARCHAND L. Alcohol intake and colorectal cancer risk in the Multiethnic Cohort Study. Am J Epidemiol. 2019;188(1):67–76.
- HUR J, SMITH-WARNER SA, RIMM EB, WILLETT WC, WU K, CAO Y, et al. Alcohol intake in early adulthood and risk of colorectal cancer: Three large prospective cohort studies of men and women in the United States. Eur J Epidemiol. 2021;36(3):325–33.
- WANG L, JING F, SU D, ZHANG T, YANG B, JIAO S, et al. Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: A meta-analysis. Int J Clin Exp Med. 2015;8(1):650–7.